Latest Monoclonal antibodies Stories
Three new tools for bacterial detection and isolation MILFORD, Mass., July 29, 2014 /PRNewswire/ -- KPL, a SeraCare Company, today announced the addition of three new products to its
Emerging Therapies, Especially IL-17 Inhibitors, Have Potential Relative to Current Therapies in Improving Psoriatic Plaques, According to Findings from Decision Resources Group BURLINGTON,
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Nearly half a million dollars given to early-career physicians to study psoriatic disease PORTLAND, Ore., July 17, 2014 /PRNewswire-USNewswire/ -- Twelve residents and medical students each
MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Xencor, Inc.
The increasing number of research activities, coupled with the introduction of advanced technologies in chromatography instruments and consumables, will drive the growth of chromatography systems
More Images (1 images) »